S-Allylcysteine, a garlic compound, protects against oxidative stress in 1-methyl-4-phenylpyridinium-induced parkinsonism in mice

Journal of Nutritional Biochemistry

Volumn 22, Issue 10, 2011, Pages 937-944

  Rojas, Patricia ^a   Serrano García, Norma ^a   Medina Campos, Omar N ^b   Pedraza Chaverri, José ^b   Maldonado, Perla D ^a   Ruiz Sánchez, Elizabeth ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

1 methyl 4 phenylpyridinium; Antioxidant defense; Dopamine; Neuroprotection; Parkinson's disease; S Allylcysteine

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 3,4 DIHYDROXYPHENYLACETIC ACID; 4 HYDROXYNONENAL; COPPER ZINC SUPEROXIDE DISMUTASE; DOPAMINE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HOMOVANILLIC ACID; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE; S ALLYLCYSTEINE; SUPEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BEHAVIORAL SCIENCE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DRUG EFFECT; ENZYME ACTIVITY; GARLIC; LIPID PEROXIDATION; LOCOMOTION; MALE; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSONISM; TREATMENT DURATION; UPREGULATION;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; CORPUS STRIATUM; CYSTEINE; GARLIC; GLUTATHIONE REDUCTASE; MALE; MICE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PARKINSONIAN DISORDERS; SUPEROXIDE DISMUTASE;

ALLIUM SATIVUM; MUS;

EID: 80053118896     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.08.005     Document Type: Article

References (53)

1. Lawson L.D. The composition and chemistry of garlic cloves and processed garlic. Garlic: the science and therapeutic application of Allium sativum L. and related species 1996, 37-107. Williams and Wilkins., Baltimore. H.P. Koch, L.D. Lawson (Eds.).
2. Thomson M., Ali M. Garlic (Allium sativum): a review of its potential use as an anti-cancer agent. Curr Cancer Drug Targets 2003, 3:67-81.
3. Yeh Y.Y., Liu L. Cholesterol-lowering effect of garlic extracts and organosulfur compounds: human and animal studies. J Nutr 2001, 131:9895-9935.
4. Imai J., Nagase S., Miroguchi T., Matsuura H., Itakura Y. Antioxidant and radical scavenging effects of aged garlic extract and its constituents. Planta Med 1994, 60:417-420.
5. Broek C. Antioxidant health effects of aged garlic extract. J Nutr 2001, 131:1010S-1015S.
6. Kim K.M., Chun S.B., Koo M.S., Choi W.J., Kim T.W., Kwon Y.G., et al. Differential regulation of NO availability from macrophages and endothelial cells by the garlic component S-allyl cysteine. Free Radic Biol Med 2001, 30:747-756.
7. Ide N., Lau B.H. Garlic compounds minimize intracellular oxidative stress and inhibit nuclear factor-kB activation. J Nutr 2001, 131:1020-1026.
8. Ide N., Lau B.H. Garlic compounds protect vascular endothelial cells from oxidized low density lipoprotein-induced injury. J Pharm Pharmacol 1997, 49:908-911.
9. Numagami Y., Ohnishi S.T. S-Allylcysteine inhibits free radical production, lipid peroxidation and neuronal damage in rat brain ischemia. J Nutr 2001, 131:1100S-1105S.
10. Nishiyama N., Moriguchi T., Morihara N., Saito H. Ameliorative effect of S-allylcysteine, a major thioallyl constituent in aged garlic extract, on learning deficits in senescence-accelerated mice. J Nutr 2001, 131:1093S-1095S.
11. Pérez-Severiano F, Salvatierra-Sánchez R., Rodríguez-Pérez M., Cuevas-Martínez E., Guevara J., Limón D., et al. S-Allylcysteine prevents amyloid-beta peptide-induced oxidative stress in rat hippocampus and ameliorates learning deficits. Eur J Pharmacol 2004, 489:197-202..
12. Herrera- Mundo M.N., Silva-Adaya D., Maldonado P.D., Galván-Arzate S., Andrés-Martínez L., Pérez-de la Cruz V., et al. S-Allylcysteine prevents the rat from 3-nitropropionic acid-induced hyperactivity, early markers of oxidative stress and mitochondrial dysfunction. Neurosci Res 2006, 56:39-44.
13. Peng Q., Buz'Zard A.R., Lau B.H. Neuroprotective effect of garlic compounds in amyloid-beta peptide-induced apoptosis in vitro. Med Sci Monit 2002, 8:BR328-BR337.
14. Moriguchi T., Matsuura H., Kodera Y., Itakura Y., Katsuki H., Saito H., et al. Neurotrophic activity of organosulfur compounds having a thioallyl group on cultured rat hippocampal neurons. Neurochem Res 1997, 22:1449-1452.
15. Jenner P. Clues to the mechanism underlying dopamine cell death in Parkinson's disease. J Neurol Neurosurg Psychiatry (special suppl) 1989, 22-28.
16. Owen A.D., Schapira A.H.V., Jenner P., Marsden C.D. Oxidative stress and Parkinson's disease. Ann N Y Acad Sci 1996, 786:217-223.
17. Reiter R.J. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J 1995, 9:526-533.
18. Halliwel B. Oxygen radicals as key mediators in neurological disease: fact or fiction?. Ann Neurol 1992, 32:S10-S15.
19. Niki E., Noguchi N., Gotoh N. Dynamics of lipid peroxidation and its inhibition by antioxidants. Biochem Soc Trans 1993, 21:313-317.
20. Youdim M.B.H., Ben-Schachar D., Riederer P. Is Parkinson's disease a progressive siderosis of substantia nigra resulting in increased iron and melanin induced neurodegeneration?. Acta Neurol Scand 1989, 126:47-54.
21. Sian J., Dexter D.T., Lees A.J., Daniel S., Agid Y., Javoy-Agid F., et al. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting the basal ganglia. Ann Neurol 1994, 36:348-355.
22. Dexter D.T., Carter C.J., Wells F.R., Javoy-Agid F., Agid Y., Lees A., et al. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem 1989, 52:381-389.
23. Przedborski S., Jackson-Lewis V., Djaldetti R., Liberatore G., Vila M., Vukosavic S., et al. The parkinsonian toxin MPTP: action and mechanism. Restor Neurol Neurosci 2000, 16:135-142.
24. Sriram K., Pai K.S., Boyd M.R., Ravindranath V. Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice. Brain Res 1997, 749:44-52.
25. Wong S.S., Li R.H., Stadlin A. Oxidative stress induced by MPTP and MPP(+): selective vulnerability of cultured mouse astrocytes. Brain Res 1999, 836:237-244.
26. + induced oxygen radical formation with mitochondrial enzymes. Free Radic Biol Med 1993, 15:181-186.
27. Zhang Y., Marcillat O., Giulivi C., Ernster L., Davies K.J. The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J Biol Chem 1990, 265:16330-16336.
28. Ferger B., Spratt C., Teismann P., Seitz G., Kuschinsky K. Effects of cytisine on hydroxyl radicals in vitro and MPTP-induced dopamine depletion in vivo. Eur J Pharmacol 1998, 360:155-163.
29. Mohanakumar K.P., Muralikrishnan D., Thomas B. Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. Brain Res 2000, 864:281-290.
30. Park S.W., Kim S.H., Park K.H., Kim S.D., Kim J.Y., Baek S.Y., et al. Preventive effect of antioxidants in MPTP-induced mouse model of Parkinson's disease. Neurosci Lett 2004, 363(3):243-246.
31. Maldonado P.D., Barrera D., Rivero I., Mata R., Medina-Campos O.N., Hernández-Pando R., et al. Antioxidant S-allylcysteine prevents gentamicin-induced oxidative stress and renal damage. Free Radic Biol Med 2003, 35:317-324.
32. Garcia E., Limon D., Perez-De-La-Cruz V., Giordano M., Diaz-Muñoz M., Maldonado P.D., et al. Lipid peroxidation, mitochondrial dysfunction and neurochemical and behavioural deficits in different neurotoxic models: protective role of S-allylcysteine. Free Radic Res 2008, 42(10):892-902.
33. +-induced lipid peroxidation in mouse corpus striatum. Neurochem Res 2001, 26:1245-1251.
34. + administration to mice. Pharmacol Toxicol 1993, 72:364-368.
35. 2c) receptors in rat prefrontal cortex. J Pharmacol Exp Ther 2003, 306:734-743.
36. Valkonen M., Kuusi T. Spectrophotometric assay for total peroxyl radical-trapping antioxidant potential in human serum. J Lipid Res 1997, 38(4):823-833.
37. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
38. Gérard-Monnier D., Erdelmeier I., Régnard K., Moze-Henry N., Yadan J.C., Chaudière J. Reactions of 1-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Analytical applications to a colorimetric assay of lipid peroxidation. Chem Res Toxicol 1998, 11:1176-1183.
39. Rojas P., Serrano-García N., Mares-Sámano J.J., Medina-Campos O.N., Pedraza-Chaverri J., Ogren S.O. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice: role of oxidative stress. Eur J Neurosci 2008, 28:41-50.
40. Pedraza-Chaverrí J., Maldonado P.D., Medina-Campos O.N., Olivares-Corichi I.M., Granados-Silvestre M.A., Hernández-Pando R., et al. Garlic ameliorates gentamicin nephrotoxicity: relation to antioxidant enzymes. Free Radic Biol Med 2000, 29:602-611.
41. Carlberg I., Mannervik B. Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J Biol Chem 1975, 250:5475-5480.
42. Mattson M.P. Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity. Trends Neurosci 1998, 21:53-57.
43. Horie T., Awazu S., Itakura Y., Fuwa T. Identified diallyl polysulfides from an aged garlic extract which protects the membranes from lipid peroxidation. Planta Med 1992, 58:468-469.
44. Lewin G., Popov I. Antioxidant effects of aqueous garlic extract. 2nd communication: Inhibition of the Cu(2+)-initiated oxidation of low density lipoproteins. Arzneimittelforschung 1994, 44:604-607.
45. Sahin E., Gumuslu S. Cold-stress-induced modulation of antioxidant defence: role of stressed conditions in tissue injury followed by protein oxidation and lipid peroxidation. Int J Biometeorol 2004, 48:165-171.
46. Yurek D.M., Deutch A.Y., Roth R.H., Sladek J.R. Morphological, neurochemical, and behavioral characterizations associated with the combined treatment of diethyldithiocarbamate and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Brain Res 1989, 497:250-259.
47. Przedborski S., Kostic V., Jackson-Lewis V., Naini A.B., Simonetti S., Fahn S., et al. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J Neurosci 1992, 12:1658-1667.
48. Medina-Campos O.N., Barrera D., Segoviano-Murillo S., Rocha D., Maldonado P.D., Mendoza-Patiño N., et al. S-Allylcysteine scavenges singlet oxygen and hypochlorous acid and protects LLC-PK1 cells of potassium dichromate-induced toxicity. Food Chem Toxicol 2007, 45:2030-2039.
49. Amagase H. Clarifying the real bioactive constituents of garlic. J Nutr 2006, 136(3 Suppl):716S-725S.
50. Imada O. Toxicity aspects of garlic. Proceedings of the First World Congress on the Health Significance of Garlic and Garlic Constituents 1990, 1-47. Nutrition International, Irvine, CA.
51. Kodera Y., Suzuki A., Sumioka I., Kanezawa A., Taru N., Fujikawa M., et al. Physical, chemical and biological properties of S-allylcysteine, an amino acid derived from garlic. J Agr Food Chem 2002, 30:622-632.
52. Amagase H., Petesch B., Matsuura H., Kasuga S., Itakura Y. Intake of garlic and its bioactive components. J Nutr 2001, 131:955S-962S.
53. Sumiyoshi H., Kanezawa A., Masamoto K., Harada H., Nakagami S., Yokota A., et al. Chronic toxicity test of garlic extract in rats. J Toxicol Sci 1984, 9:61-75.